| Pharmaceutical active ingredients: |
| Ethinyl EstradiolNorethindrone Acetate |
| Available forms, composition and doses of Milli Anovlar: |
| N / A |
| Milli Anovlar medical category: |
| Human:Oral contraceptives |
| Indications and usages, anatomical therapeutic chemical and diseases classification codes: |
| G03AA05 - Norethisterone and estrogenG03AB04 - Norethisterone and estrogenG03CA01 - Ethinylestradiol |
| Pharmaceutical companies: manufacturers, researchers, developers, local distributors and suppliers: |
| Bayer Schering Pharma |
| Trade name |
Active ingredients |
Pharmaceutical company |
|
Loestrin | Ethinyl Estradiol; Norethindrone Acetate | Pfizer; Galen; Parke-Davis; Warner Chilcott |
| Loestrin 1.5 / 30 | Ethinyl Estradiol; Norethindrone Acetate | Pfizer; Warner Chilcott |
| Loestrin 1.5 / 30 21 Day Pak | Ethinyl Estradiol; Norethindrone Acetate | Pfizer; Warner Chilcott |
| Loestrin 1.5 / 30 28 Day Pack | Ethinyl Estradiol; Norethindrone Acetate | Pfizer; Warner Chilcott |
| Microgestin | Ethinyl Estradiol; Norethindrone Acetate | Watson Pharmaceuticals |
| Minestril | Ethinyl Estradiol; Norethindrone Acetate | Pfizer |
| Minestrin | Ethinyl Estradiol; Norethindrone Acetate | Pfizer; Galen; Warner Chilcott |
| Minestrin 1 / 20 | Ethinyl Estradiol; Norethindrone Acetate | Pfizer; Warner Chilcott |
| Miniphase | Ethinyl Estradiol; Norethindrone Acetate | Bayer Schering Pharma |
| Minovlar | Ethinyl Estradiol; Norethindrone Acetate | Bayer Schering Pharma |